SCHEMBL10243843

SCHEMBL10243843

O=C(c1ccc2c(c1)OCCO2)N1[C@@H]2CC[C@H]1C[C@@H](c1ccc(F)c(F)c1)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ MAOB P27338 4/20 0.50
▸ HPGD P15428 3/20 0.46
▸ TSHR P16473 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MGLL Q99685 1/20 0.45
▸ RECQL P46063 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ SCD5 Q86SK9 1/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42
▸ PKLR P30613 1/20 0.41
▸ CHRNA7 P36544 1/20 0.41
▸ CTNNB1 P35222 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17350919 1.00 LMNA (0.54) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL10243878 0.90 ALDH1A1 (0.47) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL17350779 0.89 ALDH1A1 (0.53) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL10243800 0.89 ALDH1A1 (0.53) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL10243882 0.86 MAOB (0.51) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL10243619 0.85 TSHR (0.48) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL2683635 0.85 TSHR (0.48) LMNAALDH1A1HSD17B10MAOBHPGD
SCHEMBL10243945 0.85 TSHR (0.48) LMNAALDH1A1HSD17B10HPGDTSHR
SCHEMBL17350804 0.85 TSHR (0.48) LMNAALDH1A1HSD17B10HPGDTSHR
SCHEMBL10243991 0.84 RAB9A (0.51) LMNAALDH1A1MAOBHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318403-B1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INT (DE) 2015-12-23 — — EP disclosed
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use HSD11B1, HSD11B2, HSD17B1 LMNA 2595/4885ALDH1A1 141/4885HSD17B10 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback